Filed: 11/14/2024ACC: 0001420506-24-002530
📋 What this filing means
ALTIUM CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 77 equity positions with a total reported market value of $339.71M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
77
Positions
$339.71M
Total AUM (reported)
41.71M
Total Shares
Allocation by class
COM$230.42M67.8%
COM NEW$46.71M13.8%
CL A$37.30M11.0%
COM PAR $.01$9.49M2.8%
COM SHS$8.00M2.4%
SPONSORED ADS$5.00M1.5%
CLASS A ORD$2.02M0.6%
Portfolio Concentration
Top 3$78.65M23.2%
4–10$82.55M24.3%
11–25$103.50M30.5%
Rest$75.00M22.1%
Top 3 weight
23.2%
Top 10 weight
47.5%
Voting Authority Distribution
Total shares with voting rights: 41.71M
Sole
Full voting authority
41.71M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole77
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings77
Rows:
VERA THERAPEUTICS INC
SOLEShares684K
TypeSH
Market value$30.23M
8.90%
Sole
684K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares1.36M
TypeSH
Market value$27.19M
8.00%
Sole
1.36M
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares170K
TypeSH
Market value$21.23M
6.25%
Sole
170K
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
SOLEShares222K
TypeSH
Market value$14.65M
4.31%
Sole
222K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares370K
TypeSH
Market value$14.57M
4.29%
Sole
370K
Shared
0.00
None
0.00
ZEVRA THERAPEUTICS INC
SOLEShares1.70M
TypeSH
Market value$11.80M
3.47%
Sole
1.70M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares154K
TypeSH
Market value$11.27M
3.32%
Sole
154K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares212.91K
TypeSH
Market value$10.75M
3.16%
Sole
212.91K
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares77K
TypeSH
Market value$10.03M
2.95%
Sole
77K
Shared
0.00
None
0.00
INSMED INC
SOLEShares130K
TypeSH
Market value$9.49M
2.79%
Sole
130K
Shared
0.00
None
0.00
MERIT MED SYS INC
SOLEShares85K
TypeSH
Market value$8.40M
2.47%
Sole
85K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.70M
TypeSH
Market value$8.24M
2.43%
Sole
1.70M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares72K
TypeSH
Market value$8.23M
2.42%
Sole
72K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares610K
TypeSH
Market value$8.00M
2.36%
Sole
610K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares126K
TypeSH
Market value$7.98M
2.35%
Sole
126K
Shared
0.00
None
0.00
CATALYST PHARMACEUTICALS INC
SOLEShares385K
TypeSH
Market value$7.65M
2.25%
Sole
385K
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares369.13K
TypeSH
Market value$7.07M
2.08%
Sole
369.13K
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS IN
SOLEShares355K
TypeSH
Market value$6.88M
2.02%
Sole
355K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares1.57M
TypeSH
Market value$6.68M
1.97%
Sole
1.57M
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares86K
TypeSH
Market value$6.38M
1.88%
Sole
86K
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
SOLEShares889K
TypeSH
Market value$5.82M
1.71%
Sole
889K
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares355K
TypeSH
Market value$5.75M
1.69%
Sole
355K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares131K
TypeSH
Market value$5.67M
1.67%
Sole
131K
Shared
0.00
None
0.00
RXSIGHT INC
SOLEShares112K
TypeSH
Market value$5.54M
1.63%
Sole
112K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares58K
TypeSH
Market value$5.21M
1.53%
Sole
58K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERA THERAPEUTICS INCSOLE | CL A | 684K | SH | $30.23M 8.90% | 684K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 1.36M | SH | $27.19M 8.00% | 1.36M | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 170K | SH | $21.23M 6.25% | 170K | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPSOLE | COM | 222K | SH | $14.65M 4.31% | 222K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 370K | SH | $14.57M 4.29% | 370K | 0.00 | 0.00 |
ZEVRA THERAPEUTICS INCSOLE | COM NEW | 1.70M | SH | $11.80M 3.47% | 1.70M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 154K | SH | $11.27M 3.32% | 154K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 212.91K | SH | $10.75M 3.16% | 212.91K | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 77K | SH | $10.03M 2.95% | 77K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 130K | SH | $9.49M 2.79% | 130K | 0.00 | 0.00 |
MERIT MED SYS INCSOLE | COM | 85K | SH | $8.40M 2.47% | 85K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.70M | SH | $8.24M 2.43% | 1.70M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 72K | SH | $8.23M 2.42% | 72K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | COM SHS | 610K | SH | $8.00M 2.36% | 610K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 126K | SH | $7.98M 2.35% | 126K | 0.00 | 0.00 |
CATALYST PHARMACEUTICALS INCSOLE | COM | 385K | SH | $7.65M 2.25% | 385K | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 369.13K | SH | $7.07M 2.08% | 369.13K | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INSOLE | COM | 355K | SH | $6.88M 2.02% | 355K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 1.57M | SH | $6.68M 1.97% | 1.57M | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 86K | SH | $6.38M 1.88% | 86K | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCSOLE | COM | 889K | SH | $5.82M 1.71% | 889K | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 355K | SH | $5.75M 1.69% | 355K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 131K | SH | $5.67M 1.67% | 131K | 0.00 | 0.00 |
RXSIGHT INCSOLE | COM | 112K | SH | $5.54M 1.63% | 112K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 58K | SH | $5.21M 1.53% | 58K | 0.00 | 0.00 |
Page 1 of 4